Insider Cluster (2 insiders) ·Filed Aug 7, 2026

ACAD

ACADIA PHARMACEUTICALS INC
NEUTRAL
Impact 2/10
Horizonimmediate Processed1mo ago
Insider cluster: 2 insiders, $601K total
Actionable Insight • Neutral

Monitor for upcoming catalysts (e.g., pipeline updates, FDA decisions) but this insider activity is routine and not predictive. No trade signal from this cluster.

DirectionNeutral
Confidencehigh
Horizonimmediate
Latest settled — T+20d
ACAD ▼ -6.16% at T+20d
NEUTRAL call ✗ call lost -6.16% · α vs SPY -5.24% · entry $29.39 → $27.58
Next anchor: T+60d in 4w
Latest observation: T+36 -48.01% FF3 residual α
Entry anchored
Aug 7, 2026
via day open
T+1d
+0.07%
call +0.07% · α +0.39%
$29.41
settled 8w ago
T+5d
-1.29%
call -1.29% · α -1.25%
$29.01
settled 7w ago
T+20d
-6.16%
call -6.16% · α -5.24%
$27.58
settled 28d ago
T+60d
—
call — · α —
—
in 4w

Price Chart

Loading chart...

Executive Summary

Two ACAD insiders (CFO and EVP R&D) sold a combined $601K in open-market transactions over a 7-day window. The total represents only 0.012% of the $4.9B market cap, making this a routine, non-informative cluster. No material signal for the stock.

Key Financial Metrics

Direction
selling
Total Value
$601.0K
Insiders
2

Key Facts

  • Total open-market sales: $601K (0.012% of $4.9B market cap)
  • CFO Schneyer sold $315K (including derivative exercises) and EVP R&D Thompson sold $431K
  • Derivative exercises by CFO were non-cash ($0 value) and do not affect sentiment
  • Insider selling is trivial relative to company size and likely liquidity-driven

Financial Impact

Negligible — $601K is 0.012% of market cap

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
78% bullish (27 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-ACAD-1786140072266
9 reports for ACAD
Performance horizon
67% Hit rate 2 of 3 directional calls best @ T+20▲ +5.01%May 6, 2026
Filters
Rows
Reports for ACAD — sortable, filterable
TypeNow
Sep 11, 2026
20d ago
8-K
NEUTRAL ★ 3/10
$27.52 $26.40▼ −4.09%▼ −4.19%$19.95 (−27.51%)
Aug 17, 2026
6w ago
Institutional Cluster
MIXED ★ 5/10
$29.01 $29.65▲ +2.21%▲ +3.40%$19.95 (−31.23%)
Aug 7, 2026
7w ago
Insider Cluster
NEUTRAL ★ 2/10
$29.39 $29.01▼ −1.29%▼ −1.25%$19.95 (−32.12%)
Jun 11, 2026
16w ago
Institutional Cluster
BEARISH ★ 6/10
$21.39 $21.60▼ −0.98%▼ −0.55%$19.95 (+6.73%)
May 6, 2026
21w ago
8-K
BEARISH ★ 6/10
$22.56 $22.18▲ +1.68%▲ +3.19%$19.95 (+11.57%)
May 4, 2026
21w ago
Insider Cluster
NEUTRAL ★ 2/10
$22.19 $21.80▼ −1.76%▼ −4.69%$19.95 (−10.09%)
Mar 25, 2026
27w ago
Insider Cluster
NEUTRAL ★ 4/10
$22.01 $22.32▲ +1.41%▲ +1.65%$19.95 (−9.36%)
Mar 5, 2026
30w ago
8-K
NEUTRAL ★ 3/10
$22.40 $21.27▼ −5.04%▼ −2.81%$19.95 (−10.94%)
Feb 25, 2026
31w ago
8-K
BULLISH ★ 8/10
$24.64 $22.40▼ −9.09%▼ −7.96%$19.95 (−19.03%)
Showing 9 of 9

US Market Status

Market Closed — Opens Mon (65h 29m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published Aug 7, 2026